Hikma Pharmaceutical | HIK - Operating Expenses

Stock Price
1,652.00
Daily Change
33.00 2.04%
Monthly
5.36%
Yearly
-28.05%
Q1 Forecast
1,600.34

Hikma Pharmaceutical reported $642M in Operating Expenses for its fiscal semester ending in June of 2025.





Operating Expenses Change Date
Almirall EUR 517.43M 43.18M Jun/2025
argenx SE USD 776.99M 32.87M Sep/2025
AstraZeneca USD 12.53B 4.16B Dec/2025
Autolus Therapeutics Ltd USD 82.61M 8.39M Jun/2025
Bayer EUR 10.2B 523M Sep/2025
Fresenius EUR 4.91B 110M Sep/2025
Galapagos EUR 112.83M 9.48M Sep/2025
Genmab DKK 565M 38M Jun/2025
GlaxoSmithKline GBP 7.18B 1.42B Dec/2025
GRIFOLS EUR 1.51B 28.3M Sep/2025
Hikma Pharmaceutical USD 642M 663M Jun/2025
Lonza CHF 3.09B 564M Dec/2024
Merck EUR 4.11B 117M Sep/2025
Orion EUR 367.1M 64.9M Dec/2025
Recordati EUR 384.01M 82.67M Dec/2025
Roche Holding CHF 21.01B 10.84B Dec/2025
Sanofi EUR 10.51B 1.21B Dec/2025
UCB EUR 2.36B 108M Dec/2024